These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Protection of pancreatic beta-cells: is it feasible? Bonora E Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375 [TBL] [Abstract][Full Text] [Related]
4. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA; Nathan MS; Beattie P Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of the patient with type 2 diabetes. Quinn L Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs]. Landgraf R MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292 [TBL] [Abstract][Full Text] [Related]
7. [Therapy with oral antidiabetic drugs]. Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study. Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976 [TBL] [Abstract][Full Text] [Related]
9. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus. Campbell RK Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs. Efendic S; Alvarsson M; Brismar K; Wagner H Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. Yki-Järvinen H Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes. Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120 [TBL] [Abstract][Full Text] [Related]
15. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Snyder RW; Berns JS Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745 [TBL] [Abstract][Full Text] [Related]
16. Rational choice of oral antihyperglycaemic agents. Chowdhury S; Sengupta N J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278 [TBL] [Abstract][Full Text] [Related]
17. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients. Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377 [TBL] [Abstract][Full Text] [Related]
18. [Modern approaches to pharmacotherapy of diabetes mellitus type II]. Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608 [TBL] [Abstract][Full Text] [Related]
19. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886 [TBL] [Abstract][Full Text] [Related]
20. Intensifying insulin therapy in patients with type 2 diabetes mellitus. Hirsch IB Am J Med; 2005 May; 118 Suppl 5A():21S-6S. PubMed ID: 15850550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]